Novartis | NVS - Trade Creditors

Stock Price
153.18
Daily Change
3.39 2.26%
Monthly
11.10%
Yearly
39.50%
Q1 Forecast
145.07

Novartis reported $4.56B in Trade Creditors for its fiscal quarter ending in September of 2025.





Trade Creditors Change Date
AbbVie USD 32.25B 1.2B Jun/2025
Amgen USD 19.64B 1.61B Sep/2025
AstraZeneca USD 25.03B 1.04B Sep/2025
Bausch Health Companies USD 616M 11M Sep/2025
Biogen USD 413.1M 4.7M Sep/2025
Bristol-Myers Squibb USD 4.29B 1.14B Sep/2025
Canopy Growth CAD 18.14M 5.94M Sep/2025
Corcept Therapeutics USD 34.45M 10.92M Sep/2025
Drreddys Laboratories INR 454.04M 854K Dec/2025
Eli Lilly USD 4.26B 186.5M Sep/2025
Gilead Sciences USD 808M 226M Sep/2025
GlaxoSmithKline GBP 15.68B 855M Sep/2025
Glaxosmithkline GBP 21.07B 7.42B Sep/2025
J&J USD 9.62B 161M Sep/2025
Merck USD 4.15B 102M Sep/2025
Novartis USD 4.56B 49M Sep/2025
Novartis USD 4.56B 49M Sep/2025
Pacira USD 17.69M 12.44M Sep/2025
Perrigo USD 469.7M 19.3M Sep/2025
Pfizer USD 5.02B 142M Sep/2025
Prestige Brands USD 41.92M 19.72M Sep/2025
Roche Holding CHF 5.78B 1.27B Dec/2025
Sanofi EUR 22.93B 927M Dec/2025
Sanofi EUR 22.93B 2.89B Dec/2025
Supernus Pharmaceuticals USD 108.61M 100.4M Sep/2025
Zoetis USD 410M 98M Sep/2025